Two novel GJA1 variants in oculodentodigital dysplasia.

Nikolai P Pace, Valerie Benoit, David Agius, Maria Angela Grima, Raymond Parascandalo, Pascale Hilbert, Isabella Borg

Journal: Molecular genetics & genomic medicine 2020;7(9):e882

PMID: 31347275

Abstract

BACKGROUND

Oculodentodigital dysplasia (ODDD) is a rare disorder with pleiotropic effects involving multiple body systems, caused by mutations in the gap junction protein alpha 1 (GJA1) gene. GJA1 gene encodes a polytopic connexin membrane protein, Cx43, that is a component of connexon membrane channels.

METHODS

We describe two unrelated female probands referred for a genetic review in view of a dysmorphic clinical phenotype.

RESULTS

Two novel missense mutations in GJA1 that substitute conserved amino acids in the first and second transmembrane domains (NM_000165.5: c.77T>C p.Leu26Pro and NM_000165.5:c.287T>G p.Val96Gly) were detected through targeted sequencing of GJA1. These variants were detected in the heterozygous state in the two Maltese probands and segregated with the disease phenotype.

CONCLUSION

This report further expands the mutational spectrum of ODDD.

© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.

Address: Centre for Molecular Medicine and Biobanking, University of Malta, Msida, Malta.; Département de Biologie Moléculaire, Institut de Pathologie et de Génétique ASBL, Gosselies, Belgium.; Department of Ophthalmology, Mater Dei Hospital, Msida, Malta.; Department of Medicine, Mater Dei Hospital, Msida, Malta.; Department of Pediatrics, Mater Dei Hospital, Msida, Malta.; Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.; Medical Genetics Unit, Department of Pathology, Mater Dei Hospital, Msida, Malta.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.